Cantargia AB Sweden

Cantargia successfully concludes toxicity study with CAN10 antibody ahead of phase I clinical trial application

View original content:https://www.prnewswire.co.uk/news-releases/cantargia-successfully-concludes-toxicity-study-with-can10-antibody-ahead-of-phase-i-clinical-trial-application-301721227.html